ENTITY
Legend Biotech Corp

Legend Biotech Corp (LEGN US)

103
Analysis
Health CareChina
Legend Biotech Corporation operates as a biopharmaceutical company. The Company engages in discovery and development of novel cell therapies for oncology and other indications. Legend Biotech serves customers in the State of New Jersey.
more
21 Sep 2021 21:45

Global #1 Gene Synthesis Provider, But The Stock Is Fairly Valued

Valuation of Genscript Biotech (1548 HK) reached ~$9 billion in Hong Kong. We do believe the stock has ~11% limited upside potential with free cash...

Logo
290 Views
Share
31 Aug 2021 09:11

Innovent Biologics (1801.HK) - The Strength and the Concerns

This article analyzed Innovent about 2021H1 performance, commercialized products, pipeline, concerns of the Company, and also include thoughts on...

Logo
203 Views
Share
22 Jul 2021 09:09

Pre-IPO Transcenta Holding - Insights on Pipeline and the Concerns

The article mainly analyzed Transcenta Holding in terms of its important product candidates MSB2311, TST001, TST005 and MSB0254,including the...

Logo
246 Views
Share
17 Jun 2021 13:17

CARsgen (科济药业) IPO Trading: Not Likely a Pop on Debut

We look at the updates of CARsgen since our last note. Past deals with similar book coverage didn't do well on the first day in general despite a...

Logo
287 Views
Share
07 Jun 2021 14:29

CARsgen Therapeutics IPO: Valuation Insights

Due to the full IPO price range, lack of blue-chip cornerstone support and the current weak market sentiment on IPOs, we are inclined to wait on...

Logo
443 Views
Share
x